![Peter M. Chakoutis](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Peter M. Chakoutis
Keine laufenden Positionen mehr
Karriereverlauf von Peter M. Chakoutis
Ehemalige bekannte Positionen von Peter M. Chakoutis
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
HARVARD APPARATUS REGENERATIVE TECHNOLOGY INC. | Comptroller/Controller/Auditor | - | 29.10.2020 |
Finanzdirektor/CFO | 24.02.2020 | 29.10.2020 | |
HARVARD APPARATUS REGENERATIVE TECHNOLOGY INC. | Finanzdirektor/CFO | - | 17.01.2020 |
DUSA Pharmaceuticals, Inc.
![]() DUSA Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology DUSA Pharmaceuticals, Inc. is an integrated dermatology pharmaceutical company, which develops and markets Levulan Photodynamic Therapy technology platform for the prevention and treatment of dermatological skin conditions. Its products include levulan kerastick, BLU-U and clindareach. The company was founded by D. Geoffrey Shulman on February 21, 1991 and is headquartered in Wilmington, MA. | Finanzdirektor/CFO | - | 01.04.2005 |
Ausbildung von Peter M. Chakoutis
Norwich University | Undergraduate Degree |
Bentley Graduate School of Business | Graduate Degree |
Statistik
International
Vereinigte Staaten | 5 |
Operativ
Director of Finance/CFO | 3 |
Comptroller/Controller/Auditor | 1 |
Undergraduate Degree | 1 |
Sektoral
Health Technology | 3 |
Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
HARVARD APPARATUS REGENERATIVE TECHNOLOGY INC. | Health Technology |
Private Unternehmen | 1 |
---|---|
DUSA Pharmaceuticals, Inc.
![]() DUSA Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology DUSA Pharmaceuticals, Inc. is an integrated dermatology pharmaceutical company, which develops and markets Levulan Photodynamic Therapy technology platform for the prevention and treatment of dermatological skin conditions. Its products include levulan kerastick, BLU-U and clindareach. The company was founded by D. Geoffrey Shulman on February 21, 1991 and is headquartered in Wilmington, MA. | Health Technology |
- Börse
- Insiders
- Peter M. Chakoutis
- Erfahrung